Stockscreener 앱 받기
7.76
3.47%
0.26
시간 외 거래:
7.87
0.11
+1.42%
전일 마감가:
$7.50
열려 있는:
$7.37
하루 거래량:
9,260
Relative Volume:
0.54
시가총액:
$52.45M
수익:
$22.36M
순이익/손실:
$-33.61M
주가수익비율:
-0.8064
EPS:
-9.6235
순현금흐름:
$-26.08M
1주 성능:
-11.31%
1개월 성능:
-31.08%
6개월 성능:
-19.08%
1년 성능:
-44.57%
1일 변동 폭
$7.37
$8.37
1주일 범위
$7.37
$9.37
52주 변동 폭
$5.935
$17.74
다리오 헬스 Stock (DRIO) Company Profile
명칭
Dariohealth Corp
전화
972-4-770-6377
주소
322 W 57TH ST. #33B, NEW YORK
Compare DRIO vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
7.76 | 50.69M | 22.36M | -33.61M | -26.08M | -9.6235 |
VEEV
Veeva Systems Inc
|
179.11 | 30.45B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
48.83 | 8.78B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.09B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.90B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
다리오 헬스 Stock (DRIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2022-05-13 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2021-04-22 | 개시 | Cowen | Outperform |
| 2021-03-23 | 개시 | Stifel | Buy |
| 2021-02-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-01 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2020-08-17 | 개시 | Aegis Capital | Buy |
| 2017-08-29 | 개시 | Aegis Capital | Buy |
| 2016-05-09 | 개시 | Rodman & Renshaw | Buy |
모두보기
다리오 헬스 주식(DRIO)의 최신 뉴스
DarioHealth says CFO Zvi Ben-David to retire, appoints Chen Franco-Yehuda as successor - MSN
DarioHealth Corp stock faces investor scrutiny amid digital health market shifts and cash burn conce - AD HOC NEWS
Weekly Recap: Is DarioHealth Corp a stock for growth or value investors2026 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn
If You Invested $1,000 in Dariohealth Corp (DRIO) - Stock Titan
DarioHealth files to sell 2.71M shares of common stock for holders - MSN
Insider Trends: Will DarioHealth Corp stock go up in YEARTrade Ideas & Community Shared Stock Ideas - baoquankhu1.vn
DarioHealth (DRIO): Stifel Analyst Lowers Price Target to $10 | - GuruFocus
DarioHealth Corp. (DRIO) reports Q4 loss, beats revenue estimates - MSN
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $10.00 at Stifel Nicolaus - MarketBeat
Stifel Maintains DarioHealth(DRIO.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
DarioHealth Corp. (NASDAQ:DRIO) Q4 2025 Earnings Call Transcript - Insider Monkey
DarioHealth Corp. (NASDAQ: DRIO) registers $100M shelf for future securities - Stock Titan
DarioHealth 2025 Financial Results & 2026 Revenue Growth ForecastNews and Statistics - IndexBox
DarioHealth (DRIO) Fourth Quarter 2025 Earnings Call Transcript - Bitget
DarioHealth Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
DarioHealth (DRIO) Q4 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: DarioHealth sees revenue dip in Q4 2025 By Investing.com - Investing.com Australia
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - Finviz
DarioHealth Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: DarioHealth sees revenue dip in Q4 2025 - Investing.com
DarioHealth (NASDAQ:DRIO) Issues Earnings Results - MarketBeat
DarioHealth Corp reports results for the quarter ended December 31Earnings Summary - TradingView
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
DarioHealth Q4 revenue USD 5.2 million versus Ibes estimate USD 5.05 million - marketscreener.com
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
DarioHealth Reports Strong 2025 Financial Results and Strategic Updates - Intellectia AI
DarioHealth 2025 10-K: Revenues $22.4M, Net loss per share and $61.7M loss to common stockholders - TradingView
DarioHealth (NASDAQ: DRIO) weighs options after strategic review move - Stock Titan
DarioHealth Corp. (DRIO) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
DRIO PE Ratio & Valuation, Is DRIO Overvalued - Intellectia AI
Work begins three-tired plan for State Health Plan - AOL.com
DarioHealth Corp expected to post a loss of $3.24 a shareEarnings Preview - TradingView
Performance Recap: Will DarioHealth Corp announce a stock splitQuarterly Earnings Report & Expert Approved Trade Ideas - baoquankhu1.vn
DarioHealth Corp Stock (ISIN: US23209T1051) Eyes Digital Health Expansion Amid Competitive Pressure - AD HOC NEWS
DarioHealth Corp Stock (ISIN: US23209T1051) Faces Digital Health Crossroads as Payer Pressure Mounts - AD HOC NEWS
Short Interest in DarioHealth Corp. (NASDAQ:DRIO) Drops By 24.6% - MarketBeat
DRIO SEC FilingsDariohealth Corp 10-K, 10-Q, 8-K Forms - Stock Titan
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 - The Malaysian Reserve
DarioHealth study shows blood glucose improvements in users By Investing.com - Investing.com South Africa
DarioHealth study shows blood glucose improvements in users - Investing.com Australia
DarioHealth Corp. Announces Publication of New Peer-Reviewed Research in Frontiers in Digital Health Demonstrating Substantial and Sustained Blood Glucose Improvements Among Users of the Dario Platform - marketscreener.com
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health - Nasdaq
DarioHealth (DRIO) Price Target Decreased by 13.31% to 22.70 - MSN
Dividend Watch: Is DarioHealth Corp.’s growth already priced inWeekly Profit Summary & Free Community Consensus Stock Picks - baoquankhu1.vn
Litchfield Hills Initiates Coverage of DarioHealth (DRIO) with Buy Recommendation - MSN
Novant on board with Lantern, state health plan - AOL.com
DRIO Technical Analysis & Stock Price Forecast - Intellectia AI
DRIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Th - GuruFocus
DarioHealth Corpsees increased demand for oral GLP-1 solution - marketscreener.com
Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management - PR Newswire
다리오 헬스 (DRIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.50%
2.28%
자본화:
|
볼륨(24시간):